Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001209191-23-037143

Chief Financial Officer acquired 30,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cummings Keith Lamont Chief Financial Officer 2023-06-13 Option exercise +30,750 $2.08 $63,960 185,020 D
Derivatives
Cummings Keith Lamont Chief Financial Officer 2023-06-13 Option exercise · Stock Option (Right to Buy) −30,750 97,047 D
Loading xslF345X04/doc4.xml…